Search

everythinglearnresearchcommunity

for

Search:↓

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Overexpressing IGF-1 in mice leads to skin abnormalities and tumors.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

UC.145 may be a new biomarker for predicting gastric cancer.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

AP-1 controls tumor cell type by affecting key signaling pathways.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

A mutation in the Sgkl gene causes defective hair growth in mice.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

GLI2 increases follistatin production in human skin cells.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Transglutaminase-3 is often reduced in esophageal cancer.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

Lrig1 could be a marker for advanced sebaceous carcinoma.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Noggin promotes skin tumors by activating certain cell signaling pathways.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.